Early Diagnosis of Pulmonary Nodules

Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01752114

Enrollment

684

Registered

2012-12-19

Start date

2012-10-31

Completion date

2016-12-31

Last updated

2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Precancerous Conditions

Keywords

Precancerous conditions, Carcinoma

Brief summary

This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.

Detailed description

Patients must present with previously non-diagnosed lung nodules as found on CT. There is no change to the typical standard of care that any of the investigating physicians and/or centers provide the patients enrolled in this study. The data from this study will not be used to diagnose cancer nor be used to influence treatment decisions for the study participants.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age ≥ 40 years * Smoking history: Never, Former, Current * Subject undergoing diagnostic evaluation for a lung nodule * Subject undergoing evaluation for a lung nodule by a pulmonologist, and/or by a thoracic surgeon * Baseline CT scan identifying lung nodule performed within 60 days of subject enrollment * Nodule(s) identified by CT scan previously not followed * Subject willing to provide informed consent for the collection of blood specimens

Exclusion criteria

* Nodule work-up at the time of enrollment eligibility indicates any prior attempted or completed diagnostic biopsy procedure, such as transthoracic needle aspiration, bronchoscopic biopsy or surgery * A prior CT scan is available that previously identifies the same lung nodule under consideration for study inclusion on the most current CT scan; AND the prior CT scan was performed more than 60 days before the current CT scan, irrespective of the candidate nodule's radiographic characterization such as size, density or appearance * Current diagnosis of any cancer * Prior diagnosis of any cancer within 2 years of lung nodule detection, except for non-melanoma skin cancer * Administration of blood products, e.g. packed red blood cells, fresh frozen plasma, or platelets, within 30 days of subject enrollment * History of human immunodeficiency virus (HIV) or Hepatitis C

Design outcomes

Primary

Measure	Time frame	Description
Incidence rate of adult patients diagnosed with Non-Small Cell Lung Cancer	2 years post enrollment	Incidence rate of Non-Small Cell Lung Cancer as determined by histologic or cytologic diagnosis and/or radiographically stability at 2 years post enrollment.

Countries

Canada, United States

Outcome results